Daniel Kalman, PhD

Research Program

Cell and Molecular Biology
Phone Number

404-712-2326
Email Address

dkalman@emory.edu

Biography

Daniel Kalman, PhD, is a professor in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. Dr. Kalman is a faculty member of the Microbiology and Molecular Genetics Program in the Graduate Division of Biological and Biomedical Sciences at Emory Laney Graduate School.

Education

Dr. Kalman received his PhD in Neurosciences from University of California, Los Angeles.

Titles & Roles

Professor, Department of Pathology and Laboratory Medicine

Emory University School of Medicine

Research

The general goal of Dr. Kalman's laboratory is to understand how bacterial and viral pathogens interface with the host. His lab team has focused on two mechanistic aspects of this interface: the immunological detection and clearance of the infection, and host systems utilized by the pathogen to facilitate infection.

Title/Journal	Authors	Publication Date
Blood group A enhances SARS-CoV-2 infection. Blood	SC Wu, CM Arthur, HM Jan, WF Garcia-Beltran, KR Patel, MF Rathgeber, HP Verkerke, N Cheedarla, RP Jajosky, A Paul, AS Neish, JD Roback, CD Josephson, DR Wesemann, D Kalman, S Rakoff-Nahoum, RD Cummings, SR Stowell	24/08/2023
The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas. PLoS pathogens	TL Cleverley, S Peddineni, J Guarner, F Cingolani, PK Garcia, H Koehler, ES Mocarski, D Kalman	01/05/2023
A microbiota and dietary metabolite integrates DNA repair and cell death to regulate embryo viability and aneuploidy during aging. Science advances	R Sonowal, AI Swimm, F Cingolani, N Parulekar, TL Cleverley, A Sahoo, A Ranawade, D Chaudhuri, ES Mocarski, H Koehler, K Nitsche, S Mesiano, D Kalman	24/02/2023
Author Correction: The immunoregulatory landscape of human tuberculosis granulomas. Nature immunology	EF McCaffrey, M Donato, L Keren, Z Chen, A Delmastro, MB Fitzpatrick, S Gupta, NF Greenwald, A Baranski, W Graf, R Kumar, M Bosse, CC Fullaway, PK Ramdial, E Forgó, V Jojic, D Van Valen, S Mehra, SA Khader, SC Bendall, M van de Rijn, D Kalman, D Kaushal, RL Hunter, N Banaei, AJC Steyn, P Khatri, M Angelo	01/05/2022
The immunoregulatory landscape of human tuberculosis granulomas. Nature immunology	EF McCaffrey, M Donato, L Keren, Z Chen, A Delmastro, MB Fitzpatrick, S Gupta, NF Greenwald, A Baranski, W Graf, R Kumar, M Bosse, CC Fullaway, PK Ramdial, E Forgó, V Jojic, D Van Valen, S Mehra, SA Khader, SC Bendall, M van de Rijn, D Kalman, D Kaushal, RL Hunter, N Banaei, AJC Steyn, P Khatri, M Angelo	01/02/2022
Vaccinia virus E3 prevents sensing of Z-RNA to block ZBP1-dependent necroptosis. Cell host & microbe	H Koehler, S Cotsmire, T Zhang, S Balachandran, JW Upton, J Langland, D Kalman, BL Jacobs, ES Mocarski	11/08/2021
The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A. Blood advances	SC Wu, CM Arthur, J Wang, H Verkerke, CD Josephson, D Kalman, JD Roback, RD Cummings, SR Stowell	09/03/2021
Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging. Proceedings of the National Academy of Sciences of the United States of America	DN Powell, A Swimm, R Sonowal, A Bretin, AT Gewirtz, RM Jones, D Kalman	01/09/2020
Transcriptional and posttranscriptional regulation of the locus of enterocyte effacement in Escherichia albertii. Microbial pathogenesis	M Egan, B Critelli, SP Cleary, M Marino, C Upreti, D Kalman, S Bhatt	01/10/2019
The Evasive Enemy: Insights into the Virulence and Epidemiology of the Emerging Attaching and Effacing Pathogen Escherichia albertii. Infection and immunity	S Bhatt, M Egan, B Critelli, A Kouse, D Kalman, C Upreti	01/01/2019
Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease. Blood	A Swimm, CR Giver, Z DeFilipp, S Rangaraju, A Sharma, A Ulezko Antonova, R Sonowal, C Capaldo, D Powell, M Qayed, D Kalman, EK Waller	06/12/2018
Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents. BMC pharmacology & toxicology	HK Ananthula, S Parker, E Touchette, RM Buller, G Patel, D Kalman, JS Salzer, N Gallardo-Romero, V Olson, IK Damon, T Moir-Savitz, L Sallans, MH Werner, CM Sherwin, PB Desai	04/12/2018